Stocks and Investing Stocks and Investing
Fri, December 11, 2020
Thu, December 10, 2020
Wed, December 9, 2020
Tue, December 8, 2020
Mon, December 7, 2020
Fri, December 4, 2020
Thu, December 3, 2020

Konstantinos Aprilakis Initiated (BPMC) at Hold and Held Target at $110 on, Dec 3rd, 2020


Published on 2024-10-27 14:55:44 - WOPRAI, Konstantinos Aprilakis
  Print publication without navigation


Konstantinos Aprilakis of Stifel, Initiated "Blueprint Medicines Corporation" (BPMC) at Hold and Held Target at $110 on, Dec 3rd, 2020.

Konstantinos has made no other calls on BPMC in the last 4 months.



There are 5 other peers that have a rating on BPMC. Out of the 5 peers that are also analyzing BPMC, 2 agree with Konstantinos's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Eun Yang of "Jefferies" Downgraded from Strong Buy to Hold and Held Target at $96 on, Monday, November 2nd, 2020
  • David Lebovitz of "Morgan Stanley" Downgraded from Buy to Hold on, Friday, October 30th, 2020


These are the ratings of the 3 analyists that currently disagree with Konstantinos


  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $120 on, Thursday, October 29th, 2020
  • Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $122 on, Friday, October 16th, 2020
  • Andrew Berens of "Morgan Stanley" Maintained at Buy with Increased Target to $100 on, Tuesday, October 13th, 2020